Galectin-3 drives tau-associated neuroinflammation, white matter degeneration and proteomic dysregulation
Galectin-3 is identified as a central upstream regulator linking tau pathology to neuroinflammation, proteomic dysregulation, mitochondrial dysfunction, and white matter degeneration andTargeting Gal3 represents a promising therapeutic strategy to mitigate tau-driven neurodegenerative processes.